Paper2015114
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
Clements GJ and 9 others. AIDS Res Hum Retroviruses, 1991. Cited by 257 papers, by iCite.
Cite this record
ConductScience Library. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? Papers, record 2015114. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2015114
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Envelope Protein gp120 | Major topic |
| HIV-1 | Major topic |
| HIV-2 | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antibodies, Monoclonal | |
| CD4 Antigens | |
| Cathepsin E | |
| Cathepsins | |
| Cell Line | |
| Cricetinae | |
| Electrophoresis, Polyacrylamide Gel | |
| Endopeptidases | |
| Humans | |
| Insecta | |
| Membrane Fusion | |
| Molecular Sequence Data | |
| Neutralization Tests | |
| Peptide Hydrolases | |
| Thrombin |
Source PubMed
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 257 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41295975 | Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles. | J Virol | 2025 | https://conductscience.org/library/papers/41295975 | PubMed |
| 33801906 | Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33801906 | PubMed |
| 32470085 | Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens. | PLoS One | 2020 | https://conductscience.org/library/papers/32470085 | PubMed |
| 31087560 | Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells. | Biotechnol Bioeng | 2019 | https://conductscience.org/library/papers/31087560 | PubMed |
| 29689099 | Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies. | PLoS One | 2018 | https://conductscience.org/library/papers/29689099 | PubMed |
| 28878072 | High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers. | J Virol | 2017 | https://conductscience.org/library/papers/28878072 | PubMed |
| 28133806 | Native-like Env trimers as a platform for HIV-1 vaccine design. | Immunol Rev | 2017 | https://conductscience.org/library/papers/28133806 | PubMed |
| 26458166 | Disulfide Sensitivity in the Env Protein Underlies Lytic Inactivation of HIV-1 by Peptide Triazole Thiols. | ACS Chem Biol | 2015 | https://conductscience.org/library/papers/26458166 | PubMed |
| 25911103 | The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling. | J Biol Chem | 2015 | https://conductscience.org/library/papers/25911103 | PubMed |
| 25589637 | A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene. | J Virol | 2015 | https://conductscience.org/library/papers/25589637 | PubMed |
| 24767177 | Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies. | Retrovirology | 2014 | https://conductscience.org/library/papers/24767177 | PubMed |
| 23304142 | Retrovirus entry by endocytosis and cathepsin proteases. | Adv Virol | 2012 | https://conductscience.org/library/papers/23304142 | PubMed |
| 22085380 | Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4). | J Med Chem | 2012 | https://conductscience.org/library/papers/22085380 | PubMed |
| 21565895 | Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases. | Exp Biol Med (Maywood) | 2011 | https://conductscience.org/library/papers/21565895 | PubMed |
| 20825246 | Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry. | Biochemistry | 2010 | https://conductscience.org/library/papers/20825246 | PubMed |
| 17901336 | Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. | Science | 2007 | https://conductscience.org/library/papers/17901336 | PubMed |
| 17301129 | Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding. | J Virol | 2007 | https://conductscience.org/library/papers/17301129 | PubMed |
| 16571818 | Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events. | J Virol | 2006 | https://conductscience.org/library/papers/16571818 | PubMed |
| 11861826 | Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. | J Virol | 2002 | https://conductscience.org/library/papers/11861826 | PubMed |
| 10623764 | A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line. | J Virol | 2000 | https://conductscience.org/library/papers/10623764 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CTSE | 1510 | PubTator's text mining | https://conductscience.org/library/genes/1510 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
| SCD5 | 79966 | PubTator's text mining | https://conductscience.org/library/genes/79966 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2015114
GET https://conductscience.org/api/papers/v1/2015114/cited_by?page=2